Etienne Karita

Mobile device for disease diagnosis and data tracking in resource-limited settings.

Tassaneewan Laksanasopin, Archana A Sridhara, Samuel K Sia, 2013, Clinical chemistry.

Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth

Anurag Sethi, S. Gnanakaran, Persephone Borrow, 2013, PLoS pathogens.

Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort

Ben Murrell, Jianming Tang, Adam Godzik, 2016, PLoS pathogens.

Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1

Cynthia A. Derdeyn, Eric Hunter, Brandon F. Keele, 2009, PLoS pathogens.

Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy

Jim Todd, Basia Zaba, Pam Sonnenberg, 2007, AIDS.

Role of donor genital tract HIV-1 diversity in the transmission bottleneck

Tanmoy Bhattacharya, Eric Hunter, Debrah I Boeras, 2011, Proceedings of the National Academy of Sciences.

HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage

Ben Murrell, Terri Wrin, Sergei L. Kosakovsky Pond, 2017, Immunity.

Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

Terri Wrin, Josephine Birungi, Dennis R. Burton, 2009, Journal of Virology.

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Galit Alter, David C Montefiori, Nigel Garrett, 2018, The Lancet.